Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters

Therapeutic Methods and Therapies TCIM
Database
Language
Affiliation country
Publication year range
1.
Sci Rep ; 8(1): 1165, 2018 01 18.
Article in English | MEDLINE | ID: mdl-29348607

ABSTRACT

Mitochondrial complex I (CI) deficiency is the most frequent cause of oxidative phosphorylation (OXPHOS) disorders in humans. In order to benchmark the effects of CI deficiency on mitochondrial bioenergetics and dynamics, respiratory chain (RC) and endoplasmic reticulum (ER)-mitochondria communication, and superoxide production, fibroblasts from patients with mutations in the ND6, NDUFV1 or ACAD9 genes were analyzed. Fatty acid metabolism, basal and maximal respiration, mitochondrial membrane potential, and ATP levels were decreased. Changes in proteins involved in mitochondrial dynamics were detected in various combinations in each cell line, while variable changes in RC components were observed. ACAD9 deficient cells exhibited an increase in RC complex subunits and DDIT3, an ER stress marker. The level of proteins involved in ER-mitochondria communication was decreased in ND6 and ACAD9 deficient cells. |ΔΨ| and cell viability were further decreased in all cell lines. These findings suggest that disruption of mitochondrial bioenergetics and dynamics, ER-mitochondria crosstalk, and increased superoxide contribute to the pathophysiology in patients with ACAD9 deficiency. Furthermore, treatment of ACAD9 deficient cells with JP4-039, a novel mitochondria-targeted reactive oxygen species, electron and radical scavenger, decreased superoxide level and increased basal and maximal respiratory rate, identifying a potential therapeutic intervention opportunity in CI deficiency.


Subject(s)
Acyl-CoA Dehydrogenases/genetics , Electron Transport Complex I/deficiency , Fibroblasts/enzymology , Mitochondrial Diseases/genetics , NADH Dehydrogenase/genetics , Reactive Oxygen Species/metabolism , Acyl-CoA Dehydrogenases/deficiency , Adenosine Triphosphate/agonists , Adenosine Triphosphate/biosynthesis , Electron Transport/drug effects , Electron Transport/genetics , Electron Transport Complex I/genetics , Endoplasmic Reticulum/drug effects , Endoplasmic Reticulum/metabolism , Endoplasmic Reticulum/pathology , Fibroblasts/drug effects , Fibroblasts/pathology , Free Radical Scavengers/pharmacology , Gene Expression , Humans , Membrane Potential, Mitochondrial/drug effects , Mitochondria/drug effects , Mitochondria/enzymology , Mitochondria/pathology , Mitochondrial Diseases/enzymology , Mitochondrial Diseases/pathology , NADH Dehydrogenase/deficiency , Nitrogen Oxides/pharmacology , Oxidative Phosphorylation/drug effects , Primary Cell Culture , Reactive Oxygen Species/antagonists & inhibitors
SELECTION OF CITATIONS
SEARCH DETAIL